Eastwood Bio-Medical Canada Inc (EBM.V) stock: key figures, P/E, revenue and dividend

Consumer Staples · Food Distributors · Canada · ISIN CA27783W1059

Price
1.90 CAD
Market cap
130.88 m CAD
P/E (2025)
–
P/S (2025)
167.35
Dividend yield
0.00 %
Net margin
-42.55 %
Return on equity (ROE)
20.42 %
Return on assets (ROA)
-152.11 %

Eastwood Bio-Medical Canada Inc financials

Fiscal year20242025
Revenue702,076.00 CAD782,080.00 CAD
Gross profit454,389.00 CAD550,993.00 CAD
Operating income-437,700.00 CAD-292,328.00 CAD
EBIT-437,700.00 CAD-292,328.00 CAD
Net income-455,870.00 CAD-332,767.00 CAD
Diluted EPS – continuing operations-0.01 CAD-0.00 CAD

Full history since 2013, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Eastwood Bio-Medical Canada Inc

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for bones, teeth, and health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. In addition, the company provides Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. It has a joint research agreement with BioNexus Inc. to build a platform that applies artificial intelligence to herbal ingredient prescription data in order to identify natural drug and functional food product candidates. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. operates as a subsidiary of Eastwood Bio-Medical Research Inc.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.